Your browser doesn't support javascript.
loading
[Virological diagnosis of lower respiratory tract infections]. / Diagnostic virologique des infections respiratoires basses.
Pillet, S; Gueudin, M; Plantier, J C; Vabret, A.
Affiliation
  • Pillet S; Laboratoire des agents infectieux et d'hygiène, faculté de médecine de Saint-Étienne, CHU de Saint-Étienne et GIMAP EA3064, 1, avenue Albert-Raimond, 42055 Saint-Étienne cedex 2, France; GIMAP EA 3064, faculté de médecine de Saint-Étienne, campus santé innovations, 10, rue de la Marandière, 42270 Sa
  • Gueudin M; UNIROUEN, GRAM EA2656, laboratoire de virologie, Normandie université, CHU de Rouen, 76000 Rouen, France; Fédération Normande en microbiologie, infectiologie, hygiène (FéNoMIH), CHU de Caen et de Rouen, 14000 Caen, France.
  • Plantier JC; UNIROUEN, GRAM EA2656, laboratoire de virologie, Normandie université, CHU de Rouen, 76000 Rouen, France; Fédération Normande en microbiologie, infectiologie, hygiène (FéNoMIH), CHU de Caen et de Rouen, 14000 Caen, France.
  • Vabret A; Fédération Normande en microbiologie, infectiologie, hygiène (FéNoMIH), CHU de Caen et de Rouen, 14000 Caen, France; UNICAEN, GRAM EA2656, laboratoire de virologie, Normandie université, CHU de Caen, 14000 Caen, France.
Rev Mal Respir ; 38(1): 58-73, 2021 Jan.
Article in Fr | MEDLINE | ID: mdl-33461842
INTRODUCTION: The etiological diagnosis of bronchopulmonary infections cannot be assessed with clinical, radiological and epidemiological data alone. Viruses have been demonstrated to cause a large proportion of these infections, both in children and adults. BACKGROUND: The diagnosis of viral bronchopulmonary infections is based on the analysis of secretions, collected from the lower respiratory tract when possible, by techniques that detect either influenza and respiratory syncytial viruses, or a large panel of viruses that can be responsible for respiratory disease. The latter, called multiplex PCR assays, allow a syndromic approach to respiratory infection. Their high cost for the laboratory raises the question of their place in the management of patients in terms of antibiotic economy and isolation. In the absence of clear recommendations, the strategy and equipment are very unevenly distributed in France. OUTLOOK: Medico-economic analyses need to be performed in France to evaluate the place of these tests in the management of patients. The evaluation of the role of the different viruses often detected in co-infection, especially in children, also deserves the attention of virologists and clinicians. CONCLUSIONS: The availability of new diagnostic technologies, the recent emergence of SARS-CoV-2, together with the availability of new antiviral drugs are likely to impact future recommendations for the management of viral bronchopulmonary infections.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Respiratory Tract Infections / Virus Diseases Type of study: Diagnostic_studies / Guideline / Screening_studies Limits: Humans Language: Fr Journal: Rev Mal Respir Year: 2021 Document type: Article Country of publication: France

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Respiratory Tract Infections / Virus Diseases Type of study: Diagnostic_studies / Guideline / Screening_studies Limits: Humans Language: Fr Journal: Rev Mal Respir Year: 2021 Document type: Article Country of publication: France